Nandini Mukhopadhyay Meyersohn, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Angiography | 19 | 2022 | 4506 | 1.450 |
Why?
|
Coronary Artery Disease | 18 | 2024 | 6504 | 1.010 |
Why?
|
Chest Pain | 12 | 2022 | 1095 | 0.610 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2017 | 172 | 0.520 |
Why?
|
Cardiology Service, Hospital | 1 | 2017 | 240 | 0.490 |
Why?
|
Coronary Stenosis | 4 | 2022 | 802 | 0.450 |
Why?
|
Thoracic Diseases | 1 | 2014 | 99 | 0.440 |
Why?
|
Hospitals, General | 1 | 2016 | 798 | 0.380 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 539 | 0.370 |
Why?
|
Societies, Medical | 7 | 2024 | 3923 | 0.340 |
Why?
|
Plaque, Atherosclerotic | 4 | 2024 | 1535 | 0.320 |
Why?
|
Radiography, Thoracic | 2 | 2016 | 1303 | 0.310 |
Why?
|
Predictive Value of Tests | 15 | 2022 | 15308 | 0.310 |
Why?
|
Coronary Vessels | 6 | 2022 | 3111 | 0.260 |
Why?
|
Pericardium | 2 | 2020 | 674 | 0.240 |
Why?
|
Emergency Service, Hospital | 4 | 2022 | 7873 | 0.230 |
Why?
|
Peripheral Arterial Disease | 1 | 2015 | 1274 | 0.230 |
Why?
|
Myocardial Infarction | 4 | 2022 | 11475 | 0.210 |
Why?
|
Evidence-Based Medicine | 3 | 2024 | 3689 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 8 | 2024 | 20600 | 0.190 |
Why?
|
Cardiac Volume | 1 | 2021 | 197 | 0.170 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 345 | 0.170 |
Why?
|
Adipose Tissue | 3 | 2020 | 3309 | 0.160 |
Why?
|
Vascular Diseases | 2 | 2018 | 1160 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 764 | 0.150 |
Why?
|
Nitroglycerin | 1 | 2019 | 330 | 0.150 |
Why?
|
Thoracic Injuries | 1 | 2020 | 288 | 0.150 |
Why?
|
Prognosis | 9 | 2022 | 29672 | 0.150 |
Why?
|
Endocarditis | 1 | 2021 | 349 | 0.140 |
Why?
|
Relative Biological Effectiveness | 1 | 2018 | 311 | 0.140 |
Why?
|
Diagnostic Imaging | 5 | 2022 | 3535 | 0.130 |
Why?
|
Coronary Aneurysm | 1 | 2018 | 233 | 0.130 |
Why?
|
Syncope | 1 | 2018 | 428 | 0.120 |
Why?
|
Saphenous Vein | 1 | 2018 | 516 | 0.120 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2017 | 173 | 0.120 |
Why?
|
Coronary Care Units | 1 | 2016 | 235 | 0.120 |
Why?
|
Vasodilation | 1 | 2019 | 966 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 588 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 307 | 0.120 |
Why?
|
Middle Aged | 24 | 2024 | 220835 | 0.120 |
Why?
|
Aorta | 2 | 2021 | 2040 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 989 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2018 | 576 | 0.120 |
Why?
|
Acute Coronary Syndrome | 2 | 2017 | 2191 | 0.110 |
Why?
|
Photons | 1 | 2018 | 589 | 0.110 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 505 | 0.110 |
Why?
|
Wounds, Nonpenetrating | 1 | 2020 | 806 | 0.110 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2017 | 279 | 0.110 |
Why?
|
Foramen Ovale, Patent | 1 | 2016 | 208 | 0.110 |
Why?
|
Triage | 2 | 2018 | 984 | 0.110 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2014 | 190 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2024 | 2757 | 0.100 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2018 | 832 | 0.100 |
Why?
|
Incidental Findings | 1 | 2017 | 698 | 0.100 |
Why?
|
Humans | 40 | 2024 | 761098 | 0.100 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2018 | 695 | 0.100 |
Why?
|
Registries | 5 | 2018 | 8236 | 0.090 |
Why?
|
Cardiology | 1 | 2022 | 1693 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2018 | 7400 | 0.090 |
Why?
|
Male | 24 | 2024 | 360675 | 0.090 |
Why?
|
Observer Variation | 1 | 2017 | 2611 | 0.090 |
Why?
|
Heart Ventricles | 2 | 2020 | 3812 | 0.090 |
Why?
|
Foreign Bodies | 1 | 2014 | 402 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1223 | 0.090 |
Why?
|
Acupuncture Therapy | 1 | 2014 | 486 | 0.080 |
Why?
|
Constriction, Pathologic | 2 | 2024 | 1097 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2193 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3245 | 0.080 |
Why?
|
Catheterization | 1 | 2014 | 1428 | 0.080 |
Why?
|
Prospective Studies | 10 | 2022 | 54419 | 0.080 |
Why?
|
Equipment Design | 1 | 2017 | 3509 | 0.080 |
Why?
|
Pacemaker, Artificial | 1 | 2014 | 807 | 0.080 |
Why?
|
Radiology | 1 | 2022 | 2114 | 0.080 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2019 | 139 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1966 | 0.080 |
Why?
|
Risk Assessment | 8 | 2022 | 24013 | 0.080 |
Why?
|
Surgery, Plastic | 1 | 2014 | 641 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15513 | 0.070 |
Why?
|
Female | 20 | 2024 | 392458 | 0.070 |
Why?
|
North America | 2 | 2022 | 1281 | 0.070 |
Why?
|
Risk Factors | 7 | 2022 | 74219 | 0.070 |
Why?
|
Probability | 2 | 2022 | 2478 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5115 | 0.060 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1585 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4431 | 0.060 |
Why?
|
United States | 9 | 2024 | 72337 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4538 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2571 | 0.050 |
Why?
|
Massachusetts | 1 | 2016 | 8836 | 0.050 |
Why?
|
Aged | 10 | 2022 | 169266 | 0.050 |
Why?
|
Lung | 2 | 2018 | 9979 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2019 | 80673 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20120 | 0.050 |
Why?
|
Cohort Studies | 2 | 2022 | 41486 | 0.050 |
Why?
|
Electric Countershock | 1 | 2024 | 533 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2014 | 2751 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 643 | 0.050 |
Why?
|
Electrocardiography | 3 | 2019 | 6385 | 0.040 |
Why?
|
Atrial Appendage | 1 | 2024 | 283 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 59 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 148 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 504 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13506 | 0.040 |
Why?
|
Heart Atria | 1 | 2024 | 1349 | 0.040 |
Why?
|
Troponin I | 1 | 2022 | 652 | 0.040 |
Why?
|
HIV Infections | 1 | 2024 | 17349 | 0.040 |
Why?
|
Angiography | 1 | 2022 | 1597 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 713 | 0.030 |
Why?
|
Aerosols | 1 | 2019 | 635 | 0.030 |
Why?
|
Acute Disease | 2 | 2017 | 7240 | 0.030 |
Why?
|
Thoracic Wall | 1 | 2018 | 202 | 0.030 |
Why?
|
Hypotension, Orthostatic | 1 | 2018 | 257 | 0.030 |
Why?
|
Preoperative Care | 1 | 2024 | 2242 | 0.030 |
Why?
|
Echocardiography | 2 | 2018 | 5006 | 0.030 |
Why?
|
Radiotherapy, Conformal | 1 | 2018 | 548 | 0.030 |
Why?
|
Adult | 6 | 2018 | 221083 | 0.030 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 277 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 11701 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 709 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22125 | 0.030 |
Why?
|
Inflammation | 2 | 2024 | 10758 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1039 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1504 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3133 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2018 | 1086 | 0.030 |
Why?
|
Back Pain | 1 | 2016 | 545 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1201 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12975 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2022 | 3210 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36418 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 2016 | 683 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1270 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12341 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1879 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5720 | 0.020 |
Why?
|
Aortic Valve | 1 | 2018 | 1959 | 0.020 |
Why?
|
Dyspnea | 1 | 2016 | 1347 | 0.020 |
Why?
|
Ultrasonography | 1 | 2021 | 5971 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2018 | 2218 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2545 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2018 | 2133 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2016 | 1589 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9324 | 0.020 |
Why?
|
Heart Diseases | 1 | 2018 | 2795 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58946 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16572 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15717 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9317 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15845 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 88271 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39121 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59199 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 64670 | 0.010 |
Why?
|